Lotus Lake Ventures

Total investments

50

Average round size

15M

Portfolio companies

43

Rounds per year

2.17

Lead investments

6

Follow on index

0.14

Exits

4

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologySoftwareHealth CareEnterprise SoftwareGeneticsManufacturingMedicalPharmaceuticalElectronicsBiopharma

Summary

In 2001 was created Lotus Lake Ventures, which is appeared as VC. The company was established in Asia in China. The main department of described VC is located in the Beijing.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Medical, Biotechnology. Among the various public portfolio startups of the fund, we may underline Hisign Technology, Sensylink, Kanova

The important activity for fund was in 2018. The fund is generally included in less than 2 deals every year. Deals in the range of 10 - 50 millions dollars are the general things for fund. Considering the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Lotus Lake Ventures, startups are often financed by Infotech Ventures, CrestValue, Anlongmed Fund. The meaningful sponsors for the fund in investment in the same round are Yueyin Venture Capital, Yingke Capital, Shenzhen Capital Group. In the next rounds fund is usually obtained by LYFE Capital, JD Capital, HY Capital.

Show more

Investments analytics

Analytics

Total investments
50
Lead investments
6
Exits
4
Rounds per year
2.17
Follow on index
0.14
Investments by industry
  • Health Care (14)
  • Biotechnology (12)
  • Pharmaceutical (10)
  • Medical (9)
  • Manufacturing (6)
  • Show 49 more
Investments by region
  • China (48)
Peak activity year
2023

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
11
Avg. valuation at time of investment
31M
Group Appearance index
0.86
Strategy success index
0.20

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
ACCB Biotech 01 Dec 2005 Biotechnology, Health Care, Genetics, Life Science Seed 371K Beijing, Dongcheng District, China
VDJ 06 Jun 2023 Biotechnology, Medical, Pharmaceutical Late Stage Venture Beijing, Haidian District, China

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.